Posts filed under 'Pharmaceuticals'
The media had reports that Vivimed Labs Limited may acquire a firm in Europe.
The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company.
Vivimed Labs Limited has vide its letter inter-alia stated, “The Company has nothing to comment on the news item and will make the disclosures to the Exchange as and when things materialise.”
December 6th, 2007
The media had reports that US based Avenue Capital may pick up 15% stake in Morepen Laboratories Ltd.
The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company.
Reply is awaited from Morepen Laboratories Ltd.
September 3rd, 2007
NSE Press Release
The media had reports on June 02, 2007 that Glenmark Pharmaceuticals Ltd. may announce a bonus issue.
The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company.
Glenmark Pharmaceuticals Ltd. has vide its letter inter-alia stated, “We would like to clarify that the company has not decided regarding bonus issue and confirm that the company has not given any information regarding announcement of bonus issue to the media/ any other person and therefore we have no comments on the source of the news item.”
June 5th, 2007
NSE Press Release
The equity shares of the following company shall be listed and admitted to dealings on the Exchange w.e.f. May 22, 2007. Trading shall be in the Normal Market segment – Compulsory Demat (Rolling Settlement) for all investors.
|
Sr. No.
|
Symbol
|
Name of the Company
|
ISIN Code
|
|
1
|
ANKURDRUGS
|
Ankur Drugs And Pharma Limited
|
INE238D01012
|
May 18th, 2007
NSE Press Release
The equity shares of the following company shall be listed and admitted to dealings on the Exchange w.e.f. May 9, 2007. Trading shall be in the Normal Market Segment – Compulsory Demat (Rolling Settlement) for all investors.
|
Sr. No.
|
Symbol
|
Name of the Company
|
Series
|
ISIN Code
|
|
1
|
FORTIS
|
Fortis Healthcare Limited
|
EQ
|
INE061F01013
|
May 7th, 2007
Previous Posts